Effect of simvastatin on plasma lipids, apolipoproteins and lipoprotein particles in patients with primary hypercholesterolaemia
β Scribed by J. -M. Bard; G. Luc; P. Douste-Blazy; P. Drouin; O. Ziegler; B. Jacotot; C. Dachet; J. -L. Gennes; J. -C. Fruchart
- Publisher
- Springer
- Year
- 1989
- Tongue
- English
- Weight
- 806 KB
- Volume
- 37
- Category
- Article
- ISSN
- 0031-6970
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The effects of the HMG CoA reductase inhibitors lovastatin and pravastatin on serum lipids, lipoproteins and apolipoproteins have been studied in 35 patients with primary hypercholesterolaemia. LDL cholesterol was lowered to the same extent by both agents compared on a mg basis of each drug per day.
The effect of orlistat, a nonabsorbed inhibitor of gastric and pancreatic lipases, was examined in patients with primary hyperlipidaemia (serum cholesterol \_> 6.2 retool. 1-1 and triglycerides < 5.0 mmol-1-~) not responsive to dietary change alone, In a multicentre, randomised, double-blind study,
Objective: Effective antihypertensive agents may differ in their capacity to reduce cardiovascular risk because they induce potentially atherogenic alterations in lipoprotein composition. Patients: To assess this possibility, the effects of five months' treatment with either hydrochlorothiazide (HCT